Tag: Intrinsic Evidence
-
Socket Solutions v. Import Global: Federal Circuit Demands Doctrinal Discipline Before Granting Preliminary Patent Injunctions
The Federal Circuit’s decision in Socket Solutions, LLC v. Import Global, LLC, Case No. 2025-1121 (Fed. Cir. Aug. 4, 2026), illustrates that preliminary patent injunctions do not alter the governing standards of claim construction or equitable relief. Because a preliminary injunction can remove products from the marketplace long before infringement has been finally adjudicated, courts…
-
Otsuka v. Hetero Labs: Federal Circuit Upholds Patent Injunction but Requires Rule 65(c) Bond
The Federal Circuit’s decision in Otsuka America Pharmaceutical, Inc. v. Hetero Labs Limited, Case No. 2025-2016 (Fed. Cir. July 1, 2026), upheld a preliminary injunction delaying the launch of a generic version of Nuedexta but vacated the district court’s decision allowing the patent owner to obtain that injunction without posting security under Federal Rule of…
-
Regeneron v. Amgen: Patent Infringement and Biologic Formulations
On March 14, 2025, the United States Court of Appeals for the Federal Circuit issued a decision in Regeneron Pharmaceuticals, Inc. v. Amgen Inc., affirming the district court’s denial of a preliminary injunction sought by Regeneron. This ruling is significant in the realm of the biologic pharmaceutical industry, as it centers on claim construction and…